Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical performance of a novel ultrathin strut, low-dose, sirolimus-eluting stent with abluminal-only biodegradable polymeric coating for patients undergoing percutaneous coronary intervention in the daily practice.
Prado GF Jr, Ribeiro EE, Melo PH, Pinton FA, Esteves-Filho A, Takimura CK, Mariani J Jr, Kajita LJ, Marchiori G, Araripe Falcao Bde A, Galon MZ, Soares PR, Zalc S, Lemos PA. Prado GF Jr, et al. Among authors: ribeiro ee. Cardiovasc Diagn Ther. 2015 Dec;5(6):414-9. doi: 10.3978/j.issn.2223-3652.2015.07.07. Cardiovasc Diagn Ther. 2015. PMID: 26675281 Free PMC article.
Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial.
Oliveira MD, Ribeiro EE, Campos CM, Ribeiro HB, Faillace BL, Lopes AC, Esper RB, Meirelles GX, Perin MA, Abizaid A, Lemos PA. Oliveira MD, et al. Among authors: ribeiro ee, ribeiro hb. Cardiovasc Diagn Ther. 2015 Aug;5(4):264-70. doi: 10.3978/j.issn.2223-3652.2015.07.05. Cardiovasc Diagn Ther. 2015. PMID: 26331110 Free PMC article.
Angiographic segment size in patients referred for coronary intervention is influenced by constitutional, anatomical, and clinical features.
Lemos PA, Ribeiro EE, Perin MA, Kajita LJ, de Magalhães MA, Falcão JL, Filho AE, da Gama MN, Horta PE, Marchiori GG, Spadaro AG, Martinez EE. Lemos PA, et al. Among authors: ribeiro ee. Int J Cardiovasc Imaging. 2007 Feb;23(1):1-7. doi: 10.1007/s10554-006-9119-2. Epub 2006 Jun 30. Int J Cardiovasc Imaging. 2007. PMID: 16810447
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial.
Marchini JF, Gomes WF, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Lemos PA. Marchini JF, et al. Among authors: ribeiro ee. Cardiovasc Diagn Ther. 2014 Dec;4(6):480-6. doi: 10.3978/j.issn.2223-3652.2014.12.05. Cardiovasc Diagn Ther. 2014. PMID: 25610805 Free PMC article.
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial.
Prado GFA Jr, Abizaid AAC, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Jr JM, Perin MA, Costantini C, Costa R, Costa JR, Chamie D, Campos CM, Ribeiro EE, Lemos PA. Prado GFA Jr, et al. Among authors: ribeiro ee. Rev Port Cardiol (Engl Ed). 2021 Feb;40(2):71-76. doi: 10.1016/j.repc.2020.05.017. Epub 2021 Jan 2. Rev Port Cardiol (Engl Ed). 2021. PMID: 33402278 Free article. Clinical Trial. English, Portuguese.
129 results